share_log

Rosenblatt Reiterates Sell on CME Gr, Raises Price Target to $187

Benzinga ·  Apr 25 07:54

Rosenblatt analyst Andrew Bond reiterates CME Gr (NASDAQ:CME) with a Sell and raises the price target from $185 to $187.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment